425: Strive & Semler Merger: Risks & Next Steps

Strive, Inc. and Semler Scientific, Inc. detail risks and procedural steps for their proposed business combination, including a cautionary statement on forward-looking information.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination.
• The communication, posted by Ben Pham, CFO of Strive, Inc. on October 28, 2025, serves as a cautionary statement regarding forward-looking information related to the merger.
• The document emphasizes inherent risks and uncertainties associated with the transaction, including the realization of anticipated benefits, integration challenges, and potential legal proceedings.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is primarily a procedural notice and a comprehensive disclosure of risks associated with a proposed business combination. While the merger itself implies strategic intent, the document's heavy emphasis on cautionary statements and potential negative outcomes results in a neutral sentiment, as it balances the prospect of a merger with a detailed list of potential challenges.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Expected financial benefits of the proposed transaction, including anticipated cost savings and strategic gains.

Negatives

• Potential for dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Possibility of adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.

Risks

• Occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• Possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• Outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• Possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• Possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction include anticipated strategic and financial benefits, such as cost savings and strategic gains. The companies expect to successfully integrate the combined businesses, with the timing of the closing of the proposed transaction being a key forward-looking aspect. However, these statements are subject to significant risks and uncertainties.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted the communication on X.com on October 28, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing mentions risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating that the combined entity or one of the constituent companies is either involved in or plans to adopt such strategies. This aligns with a growing trend among some public companies to incorporate digital assets into their treasury management, a strategy that carries unique market and regulatory risks.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed with the SEC on July 17, 2025.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's stock issuance, requirement for Semler Scientific stockholders to vote on the transaction.
• Customers: Risk of potential adverse reactions or changes to business relationships.
• Employees: Risk of potential adverse reactions or changes to employee relationships.
• Management: Diversion of attention from ongoing business operations and opportunities due to the merger process.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, Bitcoin treasury, digital assets, corporate governance, forward-looking statements